Skip to main content
Log in

The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma

  • Original article
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background/purpose

Heat shock protein 70 (HSP70) and glutamine synthetase (GS) have been proposed to be promising markers for the differentiation of malignant and benign hepatocellular lesions. The aim of this study was to investigate the clinicopathological significance of the expression of HSP70 and GS in surgically resected hepatocellular carcinoma (HCC).

Methods

The authors collected 412 HCC samples and 120 non-neoplastic hepatic tissue samples and performed an immunohistochemical study.

Results

HSP70 staining was observed in 282 of 392 HCC samples (71.9%), and GS immunoreactivity was observed in 212 of 395 HCC cases (53.7%). Of the several clinicopathological parameters examined, microscopic vascular invasion, a large tumor size, and a high Edmonson–Steiner grade were found to be correlated with positive staining for HSP70 (P = 0.032, 0.002, and 0.012, respectively). Survival analysis showed a correlation between HSP70 expression and disease-free survival. GS was not found to be related to clinicopathological parameters.

Conclusions

The findings of the present study suggest that HSP70 be viewed as a predictor of prognosis as well as a useful diagnostic marker for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol. 2002;8:193–9.

    PubMed  Google Scholar 

  2. Wittekind C. [Prognostic factors in liver tumors]. Verh Dtsch Ges Pathol. 1995;79:109–15.

    PubMed  CAS  Google Scholar 

  3. Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT. Biology of hepatocellular carcinoma. Ann Surg Oncol. 2008;15:962–71.

    Article  PubMed  Google Scholar 

  4. Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, et al. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology. 2007;45:725–34.

    Article  PubMed  CAS  Google Scholar 

  5. Romanucci M, Bastow T, Della Salda L. Heat shock proteins in animal neoplasms and human tumours––a comparison. Cell Stress Chaperones. 2008;13:253–62.

    Article  PubMed  CAS  Google Scholar 

  6. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol. 2007;81:15–27.

    Article  PubMed  CAS  Google Scholar 

  7. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006;31:164–72.

    Article  PubMed  CAS  Google Scholar 

  8. Sherman M, Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci. 2007;1113:192–201.

    Article  PubMed  CAS  Google Scholar 

  9. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitelev EP, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997;26:444–50.

    Article  PubMed  CAS  Google Scholar 

  10. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086–92.

    Article  PubMed  Google Scholar 

  11. Joo M, Chi JG, Lee H. Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci. 2005;20:829–34.

    Article  PubMed  CAS  Google Scholar 

  12. Lim SO, Park SG, Yoo JH, Park YM, Kim HJ, Jang KT, et al. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J Gastroenterol. 2005;11:2072–9.

    PubMed  CAS  Google Scholar 

  13. Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones. 2001;6:316–25.

    Article  PubMed  CAS  Google Scholar 

  14. Diehl JA, Yang W, Rimerman RA, Xiao H, Emili A. Hsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinase. Mol Cell Biol. 2003;23:1764–74.

    Article  PubMed  CAS  Google Scholar 

  15. Garg M, Kanojia D, Seth A, Kumar R, Gupta A, Surolia A, et al. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion. Eur J Cancer. 2010;46:207–15.

    Article  PubMed  CAS  Google Scholar 

  16. Kaur J, Das SN, Srivastava A, Ralhan R. Cell surface expression of 70 kDa heat shock protein in human oral dysplasia and squamous cell carcinoma: correlation with clinicopathological features. Oral Oncol. 1998;34:93–8.

    Article  PubMed  CAS  Google Scholar 

  17. Ralhan R, Kaur J. Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix. Clin Cancer Res. 1995;1:1217–22.

    PubMed  CAS  Google Scholar 

  18. Milicevic ZT, Petkovic MZ, Drndarevic NC, Pavlovic MD, Todorovic VN. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma-immunohistochemistry and Western blot analysis. Neoplasma. 2007;54:37–45.

    PubMed  CAS  Google Scholar 

  19. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem. 2008;283:2031–41.

    Article  PubMed  CAS  Google Scholar 

  20. Yin Y, Qin Q, Zhang W, Zhao J, Zhang C, Yu J. Overexpression of heat shock protein 70 and spontaneous cancer cell apoptosis in hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi. 2001;9:84–5.

    PubMed  CAS  Google Scholar 

  21. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10:86–103.

    Article  PubMed  CAS  Google Scholar 

  22. Li H, Sui C, Kong F, Zhang H, Liu J, Dong M. Expression of HSP70 and JNK-related proteins in human liver cancer: potential effects on clinical outcome. Dig Liver Dis. 2007;39:663–70.

    Article  PubMed  CAS  Google Scholar 

  23. Osada T, Sakamoto M, Nagawa H, Yamamoto J, Matsuno Y, Iwamatsu A, et al. Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis. Cancer. 1999;85:819–31.

    Article  PubMed  CAS  Google Scholar 

  24. Osada T, Nagashima I, Tsuno NH, Kitayama J, Nagawa H. Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma. J Hepatol. 2000;33:247–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by grant 0420090660 from the Clinical Institute of Seoul National University Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyoungbun Lee.

Additional information

E. Shin and H. S. Ryu contributed equally as first authors.

About this article

Cite this article

Shin, E., Ryu, H.S., Kim, SH. et al. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18, 544–550 (2011). https://doi.org/10.1007/s00534-010-0367-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-010-0367-0

Keywords

Navigation